bioAffinity Technologies Inc

NAS:BIAFHealthcarenasdaq_composite

$3.51−5.90%At closeAt close · Tue 20 Oct · ≈ AED 12.89 · Market cap $4.5M · Next earnings Wed 18 Nov · Extended $3.53 +0.57%

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.1	1.4	11.4	2.8	1.1	6.4	+483.5%
Cash & short-term investments	0.1	1.4	11.4	2.8	1.1	6.4	+483.5%
Receivables	0.0	0.0	0.0	0.8	1.1	0.5	−52.4%
Inventory	0.0	0.0	0.0	0.0	0.0	0.1	+94.0%
Total current assets	0.1	1.4	12.0	4.0	2.7	7.6	+180.7%
Property, plant & equipment	0.0	0.0	0.2	2.0	1.6	1.3	−22.1%
Goodwill & intangibles	0.0	0.0	0.0	2.2	2.2	2.1	−2.7%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0	—
Total assets	0.1	1.5	12.2	8.2	6.5	11.0	+68.3%
Payables	0.2	0.2	0.3	0.6	1.0	0.8	−22.8%
Short-term debt	10.0	11.2	0.3	0.5	0.2	0.4	+123.6%
Total current liabilities	11.1	13.0	1.1	2.2	3.1	2.9	−6.4%
Long-term debt	0.1	0.2	0.0	0.0	0.0	0.0	+104.7%
Total debt	10.0	11.4	0.3	1.6	1.5	1.2	−22.7%
Net debt	9.9	10.0	(11.2)	(1.2)	0.4	(5.3)	−1435.9%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	+73.8%
Total liabilities	15.2	17.2	1.1	3.4	3.9	3.7	−5.8%
Total equity	(15.1)	(15.8)	11.0	4.9	2.6	7.3	+179.7%
Retained earnings	(22.2)	(28.5)	(36.7)	(44.6)	(53.6)	(68.6)	−27.8%

USD millionsUpdated Fri 7 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.